5 Key Takeaways
-
1
Z Optics presented 6-month clinical results for the Z+ Virtual Aperture IOL at the ESCRS Congress.
-
2
The study involved 43 patients, with 100% achieving uncorrected distance vision of 20/32 or better.
-
3
No serious adverse events were reported, and all patients were free of halos after 6 months.
-
4
The Z+ IOL utilizes a monofocal platform with a virtual aperture zone to enhance visual clarity.
-
5
The Z+ IOL is also being evaluated in a multicenter clinical study across Europe.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.